Holdings of Soleus Capital Management, L.P.
82 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 55.3 % of the equity sleeve
Sector breakdown
- Health care 10.1 %
- Unattributed 89.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 98.6 %
- FR 1.3 %
- NL 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 80 | 2.1B $ | 98.61 % |
| 2 | FR | 1 | 27.2M $ | 1.27 % |
| 3 | NL | 1 | 2.6M $ | 0.12 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Krystal Biotech Inc | 1,153,087 | 297.9M $ | |
| 2 | Celcuity Inc | 1,284,378 | 146.6M $ | |
| 3 | TG Therapeutics Inc | 4,029,319 | 133.9M $ | |
| 4 | Insulet Corp | 562,500 | 118M $ | |
| 5 | United Therapeutics Corp | 187,187 | 111M $ | |
| 6 | Praxis Precision Medicines Inc | 330,517 | 106.5M $ | |
| 7 | Vericel Corp | 2,549,079 | 82M $ | |
| 8 | ANI Pharmaceuticals Inc | 820,243 | 63.1M $ | |
| 9 | Globus Medical Inc | 729,467 | 62.9M $ | |
| 10 | Geron Corp | 41,508,659 | 61.8M $ | |
| 11 | Twist Bioscience Corp | 1,226,629 | 58.3M $ | |
| 12 | Edgewise Therapeutics Inc | 1,449,915 | 45.7M $ | |
| 13 | Beta Bionics Inc | 4,354,501 | 43.6M $ | |
| 14 | Alnylam Pharmaceuticals Inc | 131,650 | 43.6M $ | |
| 15 | Syndax Pharmaceuticals Inc | 1,726,908 | 40.3M $ | |
| 16 | Indivior Pharmaceuticals Inc | 1,274,000 | 38.8M $ | |
| 17 | NeuroPace Inc | 2,932,207 | 38.6M $ | |
| 18 | Mirum Pharmaceuticals Inc | 400,306 | 37M $ | |
| 19 | BioMarin Pharmaceutical Inc | 650,572 | 36.8M $ | |
| 20 | Progyny Inc | 2,067,000 | 35.1M $ | |
| 21 | Inspire Medical Systems Inc | 576,299 | 29.7M $ | |
| 22 | Edap Tms SA | 7,309,254 | 27.2M $ | |
| 23 | Merck & Co Inc | 203,000 | 24.4M $ | |
| 24 | Organogenesis Holdings Inc | 10,085,951 | 23.9M $ | |
| 25 | Natera Inc | 119,000 | 23.8M $ | |
| 26 | Axogen Inc | 679,170 | 22.5M $ | |
| 27 | Vaxcyte Inc | 385,472 | 22.4M $ | |
| 28 | Cerus Corp | 10,753,700 | 19.6M $ | |
| 29 | Trevi Therapeutics Inc | 1,620,000 | 19.3M $ | |
| 30 | Inhibikase Therapeutics Inc | 10,875,000 | 18.3M $ | |
| 31 | Context Therapeutics Inc | 6,963,141 | 18.2M $ | |
| 32 | Vir Biotechnology Inc | 2,002,000 | 17.9M $ | |
| 33 | Travere Therapeutics Inc | 546,000 | 16.2M $ | |
| 34 | Tandem Diabetes Care Inc | 783,000 | 15M $ | |
| 35 | Nurix Therapeutics Inc | 938,163 | 14.5M $ | |
| 36 | Sionna Therapeutics Inc | 293,500 | 11.8M $ | |
| 37 | Corcept Therapeutics Inc | 285,531 | 11.5M $ | |
| 38 | JADE BIOSCIENCES INC | 796,744 | 11.2M $ | |
| 39 | Veracyte Inc | 319,912 | 10.3M $ | |
| 40 | Invivyd Inc | 7,708,727 | 10M $ | |
| 41 | C4 Therapeutics Inc | 3,803,942 | 10M $ | |
| 42 | OrthoPediatrics Corp | 615,447 | 9.8M $ | |
| 43 | Arcus Biosciences Inc | 451,983 | 9.8M $ | |
| 44 | Tango Therapeutics Inc | 450,000 | 9.4M $ | |
| 45 | Evolus Inc | 2,245,360 | 9.2M $ | |
| 46 | Enliven Therapeutics Inc | 230,869 | 9.1M $ | |
| 47 | Inhibrx Biosciences Inc | 131,000 | 8.8M $ | |
| 48 | Dexcom Inc | 140,000 | 8.8M $ | |
| 49 | Septerna Inc | 275,000 | 6.6M $ | |
| 50 | AVALO THERAPEUTICS INC | 441,978 | 6.6M $ | |
| 51 | BIODESIX INC | 416,599 | 6M $ | |
| 52 | Relmada Therapeutics Inc | 842,106 | 5.9M $ | |
| 53 | Cullinan Therapeutics Inc | 410,200 | 5.8M $ | |
| 54 | Immunovant Inc | 230,000 | 5.7M $ | |
| 55 | MBX Biosciences Inc | 178,897 | 5.3M $ | |
| 56 | IMMUNIC INC | 4,500,000 | 5M $ | |
| 57 | Larimar Therapeutics Inc | 1,066,960 | 4.8M $ | |
| 58 | Eton Pharmaceuticals Inc | 166,381 | 4.1M $ | |
| 59 | SAB Biotherapeutics Inc | 1,050,000 | 4M $ | |
| 60 | PROCEPT BIOROBOTICS CORP | 160,000 | 4M $ | |
| 61 | Structure Therapeutics Inc | 80,000 | 3.9M $ | |
| 62 | Tectonic Therapeutic Inc | 121,684 | 3.8M $ | |
| 63 | Pulmonx Corp | 2,788,323 | 3.6M $ | |
| 64 | Iovance Biotherapeutics Inc | 1,000,000 | 3.5M $ | |
| 65 | Argenx SE | 3,500 | 2.6M $ | |
| 66 | Karyopharm Therapeutics Inc | 440,000 | 2.5M $ | |
| 67 | Arrowhead Pharmaceuticals Inc | 28,479 | 1.8M $ | |
| 68 | InspireMD, Inc. | 1,045,708 | 1.7M $ | |
| 69 | Insmed Inc | 10,250 | 1.7M $ | |
| 70 | CytomX Therapeutics Inc | 300,000 | 1.4M $ | |
| 71 | CG oncology Inc | 20,000 | 1.4M $ | |
| 72 | NeoGenomics Inc | 175,000 | 1.3M $ | |
| 73 | Cogent Biosciences Inc | 10,000 | 384.9K $ | |
| 74 | Tyra Biosciences Inc | 10,000 | 383K $ | |
| 75 | STAAR Surgical Co | 20,000 | 374K $ | |
| 76 | AnaptysBio Inc | 6,000 | 332.8K $ | |
| 77 | Rapport Therapeutics Inc | 10,000 | 312.9K $ | |
| 78 | Rigel Pharmaceuticals Inc | 10,000 | 270.4K $ | |
| 79 | Zymeworks Inc | 10,000 | 250.4K $ | |
| 80 | LB Pharmaceuticals Inc | 10,000 | 246.6K $ | |
| 81 | Oruka Therapeutics Inc | 5,000 | 245.3K $ | |
| 82 | JASPER THERAPEUTICS INC | 276,312 | 242.1K $ | |